Gastrointestinal Stents Market Size & Growth Forecast 2027–2036, By Segments (Material, Type, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Gastrointestinal Stents Market size was more than USD 490.66 million in 2026 and is set to grow at a 4.94% CAGR between 2027 and 2036, reaching USD 794.68 million by 2036. The industry revenue for 2027 is calculated at USD 511.07 million.
Get more details on this report
Request Free Sample ReportGastrointestinal Stents Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 33.71% share due to established endoscopy infrastructure, high procedural volumes, and routine use of minimally invasive stenting across hospital and ambulatory gastrointestinal care pathways.
- Asia Pacific is growing at 5.99% CAGR, driven by rising procedural adoption, expanding access to endoscopic treatment in urban centers, and use of stenting as a less invasive therapeutic option.
Segment Momentum
- Biliary stents accounted for 48.12% of the market in 2026, driven by consistent demand for managing biliary obstruction through established endoscopic procedures that restore drainage and support routine clinical practice.
- Duodenal stents are expanding rapidly because they provide less invasive relief for upper intestinal obstruction, supporting faster recovery and effective endoscopic management while reducing reliance on more burdensome surgical interventions.
Market Expansion Drivers
- Rising prevalence of colorectal cancer and digestive malignancies increasing gastrointestinal stent procedures.
- Advancements in minimally invasive stent technologies improving recovery outcomes and procedural efficiency.
- Increasing early diagnosis and intervention for gastrointestinal disorders expanding stent utilization rates.
Leading Market Participants
- Major companies in the gastrointestinal stents market include Boston Scientific Corporation (United States), Medtronic plc (Ireland), Olympus Corporation (Japan), Cook Medical LLC (United States), W. L. Gore & Associates, Inc. (United States), CONMED Corporation (United States), Merit Medical Systems, Inc. (United States), ELLA-CS, s.r.o. (Czech Republic), Hobbs Medical, Inc. (United States), Cantel Medical Corporation (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 490.66 million
- 2027 Estimated Market Size: USD 511.07 million.
- Projected Market Size: USD 794.68 million by 2036
- Growth Forecast: 4.94% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Metal (Material) | Biliary Stent (Type) | Hospitals (End-use) | Biliary Disease (Application)
- Emerging Opportunity Segment: Metal (Material) | Duodenal Stent (Type) | Ambulatory Surgical Centers (End-use) | Stomach Cancer (Application)
Market Growth Drivers and Industry Trends
Rising prevalence of colorectal cancer and digestive malignancies increasing gastrointestinal stent procedures
The increasing incidence of colorectal cancer and other digestive tract malignancies is creating a larger patient population requiring interventions to manage obstruction and maintain gastrointestinal passage, thereby driving the gastrointestinal stents market growth. As tumors develop within the esophagus, colon, duodenum, or other gastrointestinal structures, stenting can provide a less invasive approach to restoring luminal patency and alleviating complications associated with blockage. Greater utilization of palliative and supportive interventions in advanced malignancies is also contributing to demand for stents suited to different anatomical locations and clinical conditions.
Advancements in minimally invasive stent technologies improving recovery outcomes and procedural efficiency
Technological improvements in stent design and minimally invasive delivery systems are strengthening the gastrointestinal stents market by enabling physicians to perform procedures with reduced tissue disruption and greater placement precision. Innovations in stent flexibility, deployment mechanisms, radial force, and delivery catheter design can improve positioning while supporting compatibility with complex gastrointestinal anatomy. These developments can reduce procedural burden and facilitate recovery compared with more invasive surgical approaches, particularly when gastrointestinal obstruction requires timely intervention.
Increasing early diagnosis and intervention for gastrointestinal disorders expanding stent utilization rates
Improved detection of gastrointestinal disorders is allowing physicians to identify structural abnormalities and obstructive conditions earlier, which will propel the gastrointestinal stents market growth by expanding opportunities for timely therapeutic intervention. Greater use of endoscopic examinations and diagnostic imaging can help clinicians assess lesions, strictures, and other conditions that may require luminal support. Earlier clinical assessment also facilitates treatment planning and enables stenting to be considered as part of an intervention strategy before complications associated with severe obstruction become more difficult to manage.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of colorectal cancer and digestive malignancies increasing gastrointestinal stent procedures | 1.80% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
| Advancements in minimally invasive stent technologies improving recovery outcomes and procedural efficiency | 1.60% | Moderate | North America, Europe | High | Mid Term |
| Increasing early diagnosis and intervention for gastrointestinal disorders expanding stent utilization rates | 1.30% | Moderate | Asia Pacific, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the gastrointestinal stents market, North America held the largest share of 33.71% in 2026, supported by a well-established healthcare infrastructure, high adoption of advanced minimally invasive procedures, and strong demand for technologies that improve the management of gastrointestinal disorders. The region benefits from broad access to specialized gastroenterology services and sophisticated diagnostic capabilities, which facilitate the use of stenting procedures across conditions such as malignant and benign gastrointestinal obstructions. Continued investment in hospital infrastructure, physician expertise, and procedural technologies is also supporting the adoption of newer stent designs that emphasize deployment accuracy, patient safety, and improved clinical outcomes. In addition, an aging population and the increasing prevalence of gastrointestinal diseases are sustaining the need for interventional treatment options, reinforcing North America's position as a major regional market.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to represent the fastest-growing regional market, driven by expanding healthcare infrastructure, improving access to specialized gastrointestinal care, and rising awareness of minimally invasive treatment approaches. Increasing healthcare expenditure across developing economies is enabling hospitals to strengthen endoscopy and interventional capabilities, while the growing availability of trained medical professionals is supporting wider adoption of gastrointestinal stenting procedures. The region is also benefiting from a large and aging patient population, increasing incidence of gastrointestinal disorders, and gradual expansion of advanced diagnostic services beyond major urban centers. Improvements in hospital modernization, medical technology adoption, and access to specialized care are likely to create additional opportunities for gastrointestinal stent manufacturers as healthcare systems across Asia Pacific continue to develop.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Minimally Invasive CareGermany emphasizes minimally invasive gastrointestinal interventions supported by advanced endoscopy capabilities and specialized clinical expertise. Demand for gastrointestinal stents is reinforced by efforts to reduce procedural complexity and improve patient recovery pathways.
France 🇫🇷
Specialized Gastroenterology ServicesFrance supports gastrointestinal stent utilization through specialized gastroenterology centers focused on minimally invasive treatment approaches. Clinical preference for endoscopic interventions contributes to sustained demand for reliable and technically advanced stent solutions.
Italy 🇮🇹
Endoscopic Treatment ExpansionItaly continues strengthening endoscopic treatment capabilities across major healthcare institutions, supporting wider application of gastrointestinal stents. Growing emphasis on less invasive gastrointestinal procedures encourages adoption of devices that enhance therapeutic effectiveness and patient management.
Japan 🇯🇵
Precision Endoscopic PracticeJapan integrates gastrointestinal stents into highly specialized endoscopic treatment pathways where precision and procedural quality remain key priorities. The country's clinical focus supports continued adoption of technologically advanced stent designs for complex gastrointestinal conditions.
South Korea 🇰🇷
Therapeutic Endoscopy FocusSouth Korea continues expanding therapeutic endoscopy services, supporting broader use of gastrointestinal stents for obstructive and complex digestive conditions. Healthcare providers increasingly adopt advanced stent technologies that improve procedural flexibility and clinical efficiency.
United States 🇺🇸
Advanced Endoscopy AdoptionThe U.S. continues adopting gastrointestinal stents as minimally invasive treatment options for complex gastrointestinal disorders. Strong utilization of advanced endoscopic procedures supports demand for innovative stent technologies that improve procedural efficiency and patient outcomes.
Segment Leadership and Growth Trends
Gastrointestinal Stents Market Share (%), by Material, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMaterial Segment Analysis: Metal (Largest & Fastest-Growing Segment)
Metal stents dominated the gastrointestinal stents market in 2026 and also represented the fastest-growing material segment, accounting for a 47.59% share. Their strong position is associated with mechanical strength, durability, and the ability to maintain luminal patency in challenging gastrointestinal conditions. Metal stents are particularly valuable where sustained structural support is required, while advances in stent design and deployment technologies are improving their clinical utility. Increasing demand for minimally invasive gastrointestinal interventions and continued refinement of stent performance are supporting the segment's leading and rapidly expanding role.
Type Segment Analysis: Biliary Stent (Largest Segment) vs Duodenal Stent (Fastest-Growing Segment)
Biliary stents held the largest position in the gastrointestinal stents market in 2026, accounting for a 48.12% share. Their prominence is supported by widespread use in managing biliary obstruction and maintaining adequate drainage in patients requiring endoscopic intervention. The growing preference for minimally invasive procedures, combined with advances in stent design and deployment techniques, is improving the effectiveness of biliary interventions. Increasing clinical demand for timely management of biliary disorders continues to sustain the segment's leading position.
Duodenal stents are the fastest-growing type segment, driven by increasing use of minimally invasive approaches for managing gastrointestinal obstruction and restoring digestive tract patency. These devices can provide an alternative to more invasive interventions for appropriate patients, supporting their role in palliative and symptom-management procedures. Improvements in stent flexibility, placement accuracy, and clinical handling are further enhancing their utility, while broader adoption of endoscopic treatment approaches is supporting growth in duodenal stent applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Material | Metal, Plastic, Others | Metal | Metal |
| Type | Biliary Stent, Esophageal Stent, Colonic Stent, Pancreatic Stent, Duodenal Stent | Biliary Stent | Duodenal Stent |
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Application | Gastrointestinal Cancer, Biliary Disease, Colorectal Cancer, Stomach Cancer, Others | Biliary Disease | Stomach Cancer |
Competitive Landscape and Market Positioning
Top players in the gastrointestinal stents market:
1. Boston Scientific Corporation (United States)
2. Medtronic plc (Ireland)
3. Olympus Corporation (Japan)
4. Cook Medical LLC (United States)
5. W. L. Gore & Associates Inc. (United States)
6. CONMED Corporation (United States)
7. Merit Medical Systems Inc. (United States)
8. ELLA-CS s.r.o. (Czech Republic)
9. Hobbs Medical Inc. (United States)
10. Cantel Medical Corporation (United States)
The gastrointestinal stents market is advancing with improved designs that enhance flexibility and patient comfort during minimally invasive procedures. Material enhancements are supporting better biocompatibility and longer functional lifespan. The gastrointestinal stents market is also seeing rising demand due to increasing adoption of endoscopic treatment approaches.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| Olympus Corporation (Japan) | |||||||
| Cook Medical LLC (United States) | |||||||
| W. L. Gore & Associates Inc. (United States) | |||||||
| CONMED Corporation (United States) | |||||||
| Merit Medical Systems Inc. (United States) | |||||||
| ELLA-CS s.r.o. (Czech Republic) | |||||||
| Hobbs Medical Inc. (United States) | |||||||
| Cantel Medical Corporation (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Boston Scientific Corporation | Oct-25 | Received FDA 510(k) clearance and CE Mark approval for Advanix™ Biliary Plastic Stents, expanding options for treating biliary strictures and malignancies. |
| Micro-Tech | Jan-25 | Initiated operations at its new Thailand Manufacturing Center in the Laem Chabang Industrial Estate to scale production for international markets. |
| Boston Scientific Corporation | Jun-24 | Announced a definitive agreement to acquire Silk Road Medical, Inc., strengthening its portfolio of minimally invasive devices and procedure solutions. |
| SafeGuard Surgical | May-24 | Received FDA breakthrough designation for the "LeakGuard" biodegradable stent, a key innovation in non-permanent gastrointestinal stenting. |
| Olympus Corporation | Jan-24 | Completed the acquisition of Taewoong Medical, integrating a robust line of metallic GI stents into its EndoTherapy product portfolio. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Gastrointestinal Stents Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Reimbursement Type | Public Insurance, Private Insurance, Self-Pay |
| Physician Specialty | Gastroenterologists, Interventional Radiologists, General Surgeons, Surgical Oncologists |
| Patient Age Group | Pediatric Patients, Adult Patients, Geriatric Patients |
Gastrointestinal Stents Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Procedure Volume and Patient Pool Opportunity Assessment |
|
| Hospital Procurement and Tendering Landscape |
|
| Reimbursement and Market Access Strategy Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the gastrointestinal stents market?
What is the projected value of the gastrointestinal stents industry by 2036?
How are changing clinical intervention patterns influencing demand in the gastrointestinal stents market?
Why are minimally invasive stent innovations shaping purchasing decisions in the gastrointestinal stents market?
Which type segment holds the largest share in the gastrointestinal stents market?
Why are duodenal stents the fastest-growing type in the gastrointestinal stents market?
Why does North America hold the largest share in the gastrointestinal stents market?
What is driving growth in the Asia Pacific gastrointestinal stents market?
Which companies are driving growth in the gastrointestinal stents landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization